Thymosin B15


Product Details

CAT No.# CS-BA-00008
Category Peptides
CAS 184973-08-8
Molecular Weight 5172.65
Molecular Formula C220H361N61O82
Purity: >98%
Synonyms: H- Ser-Asp-Lys-Pro-Asp-Leu-Ser-Glu-Val-Glu-Thr-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Asn-Thr-Glu-Glu-Lys-Asn-Thr-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Gln-Gln-Glu-Lys-Glu-Tyr-Asn-Gln-Arg-Ser-OH; seryl-α-aspartyllysylprolyl-α-aspartylleucylseryl-α-glutamylvalyl-α-glutamylthreonylphenylalanyl-α-aspartyllysylseryllysylleucyllysyllysylthreonylasparagylthreonyl-α-glutamyl-α-glutamyllysylasparagylthreonylleucylprolylseryllysyl-α-glutamylthreonylisoleucylglutamylglutamyl-α-glutamyllysyl-α-glutamyltyrosylasparagylglutamylarginylserine
Application Notes: Thymosin B15 levels are elevated in human prostate cancer and correlate positively with the Gleason tumor grade. Thymosin B15 is a potential new biochemical marker for human prostate cancer progression.
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
Thymosin B15 Worldwide Suppliers of Thymosin B15 Peptides Clearsynth CS-BA-00008

Product rating: 9 Thymosin B15 based on 20 ratings

  1. Peptides
  2. Thymosin B15

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B

This page contains information about Thymosin B15 Cas 184973-08-8 and its Peptides.

Thymosin B15 Thymosin B15 Worldwide Suppliers of Thymosin B15 Peptides Clearsynth 184973-08-8

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."